THRB and type 2 diabetes mellitus: Collectively, these findings indicate that liraglutide improves hepatic TH resistance in T2DM with NAFLD, and restoration of impaired TRβ expression in NAFLD may be a potential mechanism involved in the process of liraglutide therapy.